M
Mark D. DeBoer
Researcher at University of Virginia
Publications - 173
Citations - 7168
Mark D. DeBoer is an academic researcher from University of Virginia. The author has contributed to research in topics: Metabolic syndrome & Diabetes mellitus. The author has an hindex of 42, co-authored 154 publications receiving 5498 citations. Previous affiliations of Mark D. DeBoer include Stanford University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
The impoverished gut—a triple burden of diarrhoea, stunting and chronic disease
TL;DR: The growing evidence for this triple burden of diarrhoea and malnutrition is reviewed and potential mechanisms and interventions that must be understood and applied to prevent the loss of human potential and unaffordable societal costs caused by these vicious cycles of poverty are reviewed.
Journal ArticleDOI
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations
Loren C. Denlinger,Brenda R. Phillips,Sima K. Ramratnam,Kristie R. Ross,Nirav R. Bhakta,Juan Carlos Cardet,Mario Castro,Stephen P. Peters,Wanda Phipatanakul,Shean J. Aujla,Leonard B. Bacharier,Eugene R. Bleecker,Suzy A. A. Comhair,Andrea M. Coverstone,Mark D. DeBoer,Serpil C. Erzurum,Sean B. Fain,Merritt L. Fajt,Anne M. Fitzpatrick,Jonathan M. Gaffin,Benjamin Gaston,Annette T. Hastie,Gregory A. Hawkins,Fernando Holguin,Anne Marie Irani,Elliot Israel,Bruce D. Levy,Ngoc P. Ly,Deborah A. Meyers,Wendy C. Moore,Ross Myers,Maria Theresa D. Opina,Michael C. Peters,Mark L. Schiebler,Ronald L. Sorkness,W. Gerald Teague,Sally E. Wenzel,Prescott G. Woodruff,David T. Mauger,John V. Fahy,Nizar N. Jarjour +40 more
TL;DR: Blood eosinophils, body mass index, and bronchodilator responsiveness were positively associated with exacerbation frequency in the SARP‐3 multivariable model, and EPA may be a distinct susceptibility phenotype with implications for the targeting of exacerbation prevention strategies.
Journal ArticleDOI
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions
TL;DR: Future efforts continue to be needed to identify childhood clinical and laboratory characteristics that could be used as screening tests to predict adult disease progression, which may have utility in motivating physicians and patients' families toward lifestyle changes, ultimately improving prevention efforts.
Journal ArticleDOI
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Marc D. Breton,Lauren Kanapka,Roy W. Beck,Laya Ekhlaspour,Gregory P. Forlenza,Eda Cengiz,Melissa J Schoelwer,Katrina J. Ruedy,Emily Jost,Lori Carria,Emma Emory,Liana J Hsu,Mary C. Oliveri,Kollman C,Betsy B Dokken,Stuart A. Weinzimer,Mark D. DeBoer,Bruce A. Buckingham,Daniel R. Cherñavvsky,R. Paul Wadwa +19 more
TL;DR: In this 16-week trial involving children with type 1 diabetes, the glucose level was in the target range for a greater percentage of time with the use of a closed-loop system than with theUse of a sensor-augmented insulin pump.
Journal ArticleDOI
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
W. Gerald Teague,Brenda R. Phillips,John V. Fahy,Sally E. Wenzel,Anne M. Fitzpatrick,Wendy C. Moore,Annette T. Hastie,Eugene R. Bleecker,Deborah A. Meyers,Stephen P. Peters,Mario Castro,Andrea M. Coverstone,Leonard B. Bacharier,Ngoc P. Ly,Michael C. Peters,Loren C. Denlinger,Sima K. Ramratnam,Ronald L. Sorkness,Benjamin Gaston,Serpil C. Erzurum,Suzy A. A. Comhair,Ross Myers,Joe Zein,Mark D. DeBoer,Anne Marie Irani,Elliot Israel,Bruce D. Levy,Juan Carlos Cardet,Wanda Phipatanakul,Jonathan M. Gaffin,Fernando Holguin,Merritt L. Fajt,Shean J. Aujla,David T. Mauger,Nizar N. Jarjour +34 more
TL;DR: Compared with children with nonsevere asthma, children with severe asthma had more symptoms and more historical exacerbations, but no difference in body weight, post-bronchodilator lung function, or inflammatory markers.